Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cardiac Biomarker Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of cardiovascular diseases globally
5.1.1.2. Increasing awareness and need for early diagnosis of cardiovascular diseases
5.1.1.3. Surge in geriatric population and related heart diseases
5.1.2. Restraints
5.1.2.1. Technical issues pertinent to sample collection and storage
5.1.3. Opportunities
5.1.3.1. Emerging investment in research and development activities in cardiac biomarkers
5.1.3.2. Emerging demand for POC testing with cardiac biomarkers
5.1.4. Challenges
5.1.4.1. Concerns over regulatory and reimbursement systems
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cardiac Biomarker Market, by Type
6.1. Introduction
6.2. Brain Natriuretic Peptide or NT-proBNP
6.3. Creatine Kinase
6.4. Ischemia Modified Albumin
6.5. Myoglobin
6.6. Troponins

7. Cardiac Biomarker Market, by Location of Testing
7.1. Introduction
7.2. Laboratory Testing
7.3. Point of Care Testing

8. Cardiac Biomarker Market, by Application
8.1. Introduction
8.2. Acute Coronary Syndrome
8.3. Atherosclerosis
8.4. Congestive Heart Failure
8.5. Myocardial Infarction

9. Americas Cardiac Biomarker Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cardiac Biomarker Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Biomarker Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Beckman Coulter, Inc.
13.1.3. Becton, Dickinson and Company
13.1.4. bioM?rieux SA
13.1.5. DiaSorin S.p.A.
13.1.6. F. Hoffmann-La Roche Ltd.
13.1.7. Guangzhou Wondfo Biotech Co., Ltd.
13.1.8. Johnson & Johnson Services, Inc.
13.1.9. Olympus Corporation
13.1.10. PerkinElmer Inc.
13.1.11. Quidel Corporation
13.1.12. Randox Laboratories Ltd.
13.1.13. Siemens Healthcare GmbH
13.1.14. Thermo Fisher Scientific Inc.
13.1.15. Tosoh Corporation
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. CARDIAC BIOMARKER MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC BIOMARKER MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC BIOMARKER MARKET DYNAMICS
FIGURE 7. CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2023 VS 2030 (%)
FIGURE 10. CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CARDIAC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CARDIAC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CARDIAC BIOMARKER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. CARDIAC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC BIOMARKER MARKET SIZE, BY BRAIN NATRIURETIC PEPTIDE OR NT-PROBNP, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CARDIAC BIOMARKER MARKET SIZE, BY CREATINE KINASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CARDIAC BIOMARKER MARKET SIZE, BY ISCHEMIA MODIFIED ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CARDIAC BIOMARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CARDIAC BIOMARKER MARKET SIZE, BY TROPONINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 12. CARDIAC BIOMARKER MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CARDIAC BIOMARKER MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. CARDIAC BIOMARKER MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CARDIAC BIOMARKER MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CARDIAC BIOMARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CARDIAC BIOMARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 31. CANADA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 34. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 48. CHINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 51. INDIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 57. JAPAN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 75. THAILAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 85. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 88. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 91. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 94. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 97. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 103. ITALY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 112. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 115. POLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 118. QATAR CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 130. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 139. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CARDIAC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 147. CARDIAC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. CARDIAC BIOMARKER MARKET LICENSE & PRICING